DANAHER Inactive Instrument
DANAHER Share Price Other OTC
Equities
US2358513008
Advanced Medical Equipment & Technology
| Sales 2024 * | 23.85B 1,832B | Sales 2025 * | 25.83B 1,984B | Capitalization | 187B 14,344B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.41B 339B | Net income 2025 * | 5.26B 404B | EV / Sales 2024 * | 8.19 x |
| Net Debt 2024 * | 8.54B 656B | Net Debt 2025 * | 2.68B 206B | EV / Sales 2025 * | 7.33 x |
| P/E ratio 2024 * |
42.5
x | P/E ratio 2025 * |
35.7
x | Employees | - |
| Yield 2024 * |
0.43% | Yield 2025 * |
0.47% | Free-Float | 74.92% |
More Fundamentals
* Assessed data
More news
Latest transcript on DANAHER
More recommendations
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Steven Rales
FOU | Founder | 72 | 31/12/82 |
Rainer Blair
CEO | Chief Executive Officer | 60 | 31/12/09 |
Mitchell Rales
FOU | Founder | 67 | 31/12/82 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mitchell Rales
FOU | Founder | 67 | 31/12/82 |
Alan Spoon
BRD | Director/Board Member | 72 | 30/06/99 |
Steven Rales
FOU | Founder | 72 | 31/12/82 |
Danaher Corporation is an industrial and technologic group organized around two families of products:
- medical equipment (70.1% of net sales): diagnostic equipment, digital imaging systems, optical instruments, microscopes, consumables, etc.;
- professional instruments of analysis (29.9%): systems of quality control of waters, disinfection, etc.
Net sales are distributed geographically as follows: the United States (40.1%), China (13.2%) and other (46.7%).
Calendar
23/07/2024
- Q2 2024 Earnings Release
Related indices
| 1st Jan change | Capi. | |
|---|---|---|
| +4.32% | 212B | |
| +28.75% | 155B | |
| +35.34% | 115B | |
| +2.05% | 65.5B | |
| +15.38% | 52.87B | |
| -6.47% | 45.25B | |
| -2.77% | 39.7B | |
| +7.60% | 37.72B | |
| +20.60% | 30.38B |
